Easy To Use Patents Search & Patent Lawyer Directory
At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.
Searching:
Search by keyword, patent number, inventor, assignee, city or state:
| Patent # | Description |
|---|---|
| US-9,828,382 |
Pyrimidinone compounds as human neutrophil elastase inhibitors Pyrimidone compounds defined herein exhibit human neutrophil elastase inhibitory properties and are useful for treating diseases and condition in which HNE is... |
| US-9,828,381 |
Substituted pyrazolopyrimidines and method of use Compounds of formula (I) ##STR00001## and pharmaceutically acceptable salts thereof, wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, L.sup.1 and G.sup.1 are as... |
| US-9,828,380 |
Efficient method for the preparation of tofacitinib citrate Disclosed is a novel process for the synthesis of tofacitinib citrate on an industrial scale with high yields and purity starting with ... |
| US-9,828,379 |
Pyrrolo-pyrrole carbamate and related organic compounds, pharmaceutical
compositions, and medical uses thereof The invention provides pyrrolo-pyrrole carbamate and related organic compounds, compositions containing such compounds, medical kits, and methods for using such... |
| US-9,828,378 |
Kinase inhibitors and methods of use The present invention provides chemical entities or compounds and pharmaceutical compositions thereof that are capable of modulating certain protein kinases... |
| US-9,828,377 |
Heterocyclic compounds and uses thereof Provided herein are compounds of Formula (I'') or (A''), pharmaceutical compositions comprising the compounds, and methods of use thereof. The compounds... |
| US-9,828,376 |
Substituted N-(3-pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine
receptor kinase BTK inhibitors In one aspect, the invention relates to substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs, derivatives thereof, and related compounds, which are useful... |
| US-9,828,375 |
4-position substituted pyrazolopyrimidine derivative, and use thereof in
drug preparation The invention belongs to the technical field of organic synthetic drugs, and particularly relates to a pyrazolopyrimidine derivative and a preparation method... |
| US-9,828,374 |
Substituted pyrazino[2,2-a]isoquinoline derivatives The present invention relates to compounds of formula of formula I wherein R, R.sup.1, R.sup.2 and L are as described herein, compositions containing compounds... |
| US-9,828,373 |
2-amino-pyrido[2,3-D]pyrimidin-7(8H)-one derivatives as CDK inhibitors and
uses thereof The invention provides compounds as CDK small-molecule inhibitors and uses thereof, the compounds can be used for treating inflammation and cell proliferation... |
| US-9,828,372 |
2-(1H-indazol-3-yl)-1H-imidazo[4,5-C]pyridine and therapeutic uses thereof Indazole compounds for treating various diseases and pathologies are disclosed. More particularly, the present invention concerns the use of an indazole... |
| US-9,828,370 |
Compositions and methods for inhibiting kinases The present invention provides compounds for the prevention or treatment of cancer or a bacterial or viral infection. Additionally, the present invention... |
| US-9,828,369 |
Isoquinoline derivatives useful as inhibitors of diacylglyceride
O-acyltransferase 2 The present invention relates to a compound represented by formula I: and pharmaceutically acceptable salts thereof. The compounds of formula I are inhibitors... |
| US-9,828,368 |
Oxazole orexin receptor antagonists The present invention is directed to oxazole compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the oxazole... |
| US-9,828,367 |
Neprilysin inhibitors In one aspect, the invention relates to compounds having the formula: ##STR00001## where R.sup.1, R.sup.2, R.sup.3, R.sup.4, and R.sup.5 are as defined in the... |
| US-9,828,366 |
Bicyclic derivatives and pharmaceutical composition including the same The present invention relates to a novel bicyclic derivative that has an inhibitory activity against sodium-glucose linked transporters (SGLTs) present in the... |
| US-9,828,365 |
Fused tetracyclic heterocyclic compounds and methods of use thereof for
the treatment of viral diseases The present invention relates to novel Fused Tetracyclic Heterocyclic Compounds of Formula I: (I), wherein A, A', R.sup.2A, R.sup.2B, R.sup.7, R.sup.8, R.sup.9,... |
| US-9,828,364 |
Pyrazole compounds as BTK inhibitors The present invention encompasses compounds of the formula (I) wherein the groups R.sub.1, Cy, and Y are defined herein, which are suitable for the treatment of... |
| US-9,828,363 |
Fused pyrimidines as inhibitors of P97 complex The present invention is directed to certain fused pyrimidines having a homo or hetero cyclopentyl, cyclohexyl or cycloheptyl ring as the pyrimidine fusion... |
| US-9,828,362 |
1,4-disubstituted imidazole derivative The present invention provides a 1,4-disubstituted imidazole derivative of formula (1') wherein ring Q.sup.1 is optionally-substituted C.sub.6-10 aryl group,... |
| US-9,828,361 |
Arylmethoxy isoindoline derivatives and compositions comprising and
methods of using the same Provided are 4'-arylmethoxy isoindoline compounds, and pharmaceutically acceptable salts, solvates, clathrates, stereoisomers, and prodrugs thereof. Methods of... |
| US-9,828,360 |
Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as
TrkA kinase inhibitors Compounds of Formula (I): or stereoisomers, tautomers, or pharmaceutically acceptable salts, or solvates or prodrugs thereof, where R.sup.1, R.sup.2, R.sup.a,... |
| US-9,828,359 |
Process for the preparation of 3-substituted (indol-1-yl)-acetic acid
esters The invention relates to an industrial scale process for the preparation of a compound of general formula (I): (Formula (I)) wherein R.sup.1, R.sup.2 and... |
| US-9,828,358 |
Compositions comprising an inhibitor of lysine specific demethylase-1 Described herein are amorphous and crystalline forms of pharmaceutically acceptable salts of the lysine specific demethylase-1 inhibitor ... |
| US-9,828,357 |
Cyclic compounds The present invention provides compounds having a Toll-like receptor 4 (TLR4) signaling inhibitory action useful as preventive and therapeutic drugs of... |
| US-9,828,356 |
Processes and intermediates for the preparations of isomer free
prostaglandis Novel processes for the preparation of a compound of Formula I-2 substantially free of the 5,6-trans isomer: ##STR00001## wherein ##STR00002## R.sub.2,... |
| US-9,828,355 |
Compound, material for forming underlayer film for lithography, underlayer
film for lithography and pattern... The material for forming an underlayer film for lithography of the present invention contains a compound represented by the following general formula (1). ... |
| US-9,828,354 |
Biorefining compounds and organocatalytic upgrading methods The invention provides new methods for the direct umpolung self-condensation of 5-hydroxymethylfurfural (HMF) by organocatalysis, thereby upgrading the readily... |
| US-9,828,352 |
Phenyl carbamates and their use as inhibitors of the fatty acid amide
hydrolase (FAAH) enzyme and modulators of... The invention provides compounds of Formula (I) or pharmaceutically acceptable salts thereof ##STR00001## wherein Ar', R.sub.1, R.sub.2, R.sub.3, R.sub.4,... |
| US-9,828,351 |
Enzyme interacting agents The present disclosure relates generally, but not exclusively, to compounds and their use as enzyme interacting agents, in particular, agents which interact... |
| US-9,828,350 |
5,6-dihydro-2H-[1,4]oxazin-3-yl-amine derivatives useful as inhibitors of
beta-secretase (BACE) The present invention relates to novel 5,6-dihydro-2H-[1,4]oxazin-3-ylamine derivatives as inhibitors of beta-secretase, also known as beta-site amyloid... |
| US-9,828,349 |
1-aryl-1-hydroxy-2,3-diamino-propyl amines,
1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related... Compounds of the formula ##STR00001## where the variables have the meaning defined in the specification have analgesic and/or immunostimulant effect in mammals. |
| US-9,828,348 |
Benzimidazole derivatives and use thereof The invention provides compounds that are useful as sodium channel blockers. In one aspect, the invention provides compounds of Formula I: ##STR00001## and... |
| US-9,828,347 |
Backfunctionalized imidazolinium salts and NHC carbene-metal complexes Backfunctionalized imidazolinium salts and methods of synthesizing the same and NHC carbene-metal complexes therefrom. For backfunctionalized imidazolinium... |
| US-9,828,346 |
N-myristoyl transferase inhibitors The present invention relates to N-heterocyclic sulphonamide compounds, in particular pyrazole sulphonamide compounds, and their use as N-myristoyl transferase... |
| US-9,828,345 |
Phenylpyrazole derivatives as potent ROCK1 and ROCK2 inhibitors The present invention provides compounds of Formula (I): (I) or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the... |
| US-9,828,344 |
Inhibitors of the notch signaling pathway and secretion for use in
medicine The invention relates to dihydropyridine compounds as inhibitors of the notch signalling pathway and/or inhibitors of secretion for the treatment of... |
| US-9,828,343 |
Histone demethylase inhibitors The present invention relates generally to compositions and methods for treating cancer and neoplastic disease. Provided herein are substituted amidopyridine or... |
| US-9,828,342 |
Isatin derivatives, pharmaceutical compositions thereof, and methods of
use thereof One aspect of the invention relates to novel isatin derivative compounds and the pharmaceutical composition thereof. Another aspect of the invention relates to... |
| US-9,828,341 |
Dendritic core compounds The invention relates to compounds that are useful for the preparation of dendrimer compounds, the use of these compounds for preparing dendrimers and processes... |
| US-9,828,340 |
Asymmetric synthesis of a substituted pyrrolidine-2-carboxamide The invention relates to a process for the preparation of 4-{[(2R,3S,4R,5S)-3-(3-chloro-2-fluoro-phenyl)-4-(4-chloro-2-fluoro-pheny- ... |
| US-9,828,339 |
Biphenyl derivatives and methods for preparing same Provided are biphenyl derivatives having the structure of Formula 1: ##STR00001## stereoisomers thereof, and pharmaceutically acceptable salts thereof, wherein... |
| US-9,828,338 |
Carbamate derivatives of lactam based N-acylethanolamine acid amidase
(NAAA) inhibitors Described herein are compounds and pharmaceutical compositions which inhibit N-acylethanolamine acid amidase (NAAA). Described herein are methods for... |
| US-9,828,337 |
Lysine derivative having an isothiocyanate functional group and associated
method of use A method for treating phytophotodermatitis including the steps of applying an isothiocyanate functional surfactant to an area affected by phytophotodermatitis,... |
| US-9,828,336 |
Methods and compounds useful in the synthesis of orexin-2 receptor
antagonists The present disclosure provides compounds and methods that are useful for the preparation of compounds useful as orexin-2 receptor antagonists. |
| US-9,828,335 |
Nitrone compounds and their use in personal care Provided are compounds and compositions thereof that are useful as antioxidants in personal care formulations. The compounds are of the Formula I: ##STR00001##... |
| US-9,828,334 |
Process for preparing levomilnacipran The present invention refers to a new process for preparing levomilnacipran, in particular to a process for the resolution of racemic tw-milnacipran with a... |
| US-9,828,333 |
Compounds for the treatment of influenza The invention relates to oseltamivir derivatives as influenza neuraminidase inhibitors for treating influenza infections and to a method for producing said... |
| US-9,828,332 |
Non-peptide BDNF neurotrophin mimetics Methods and compounds for treating neurological and other disorders are provided. Included is the administering to a subject in need thereof an effective amount... |
| US-9,828,331 |
Tetrahydro-isohumulone derivatives, methods of making and using The present application provides novel tetrahydro-isohumulone (THIAA) derivatives and substantially enantiomerically pure compositions and pharmaceutical... |
File A Patent Application
- Protect your idea -- Don't let someone else file first. Learn more.
- 3 Easy Steps -- Complete Form, application Review, and File. See our process.
- Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.